Evidence map›Paper›PMID 32918579›Full record

ReviewApplied microbiology and biotechnology2020

Biotechnology of Rhodococcus for the production of valuable compounds.

Martina Cappelletti, Alessandro Presentato, Elena Piacenza, Andrea Firrincieli, Raymond J Turner, Davide Zannoni

Open access · hybridAbstract readReview
In one paragraph

Review in Applied microbiology and biotechnology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 73 papers.

0numbers the graph read from it
0cells of the map it votes in
73citing papers in PubMed
7.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

73 citing papers in PubMed, 168 citations in OpenAlex.

  1. Cell Disruption and RNA Extraction fromInternational journal of molecular sciences · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Whole-genomic and transcriptomic analyses elucidateApplied and environmental microbiology · 2026
    Article
  11. Genomic and proteomic analyses of the maize root isolateApplied and environmental microbiology · 2026
    Article
  12. Extracellular Polymeric Substances Produced by Actinomycetes of the GenusInternational journal of molecular sciences · 2026
    Review
  13. Article
  14. Article
  15. Article
  16. Plant growth-promoting endophytic microbiota from garlic bulbs.International microbiology : the official journal of the Spanish Society for Microbiology · 2025
    Article
  17. Assessing the effect of temperature onMicrobiology (Reading, England) · 2025
    Article
  18. A Marine-Derived Steroid fromMarine drugs · 2025
    Article
  19. Review
  20. Article

13 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Martina CappellettiDepartment of Pharmacy and Biotechnology (FaBiT), University of Bologna, Bologna, Italy. martina.cappelletti2@unibo.it.ORCID http://orcid.org/0000-0002-6238-8296
Alessandro PresentatoDepartment of Biological, Chemical and Pharmaceutical Sciences and Technologies (STEBICEF), University of Palermo, Palermo, Italy.
Elena PiacenzaDepartment of Biological, Chemical and Pharmaceutical Sciences and Technologies (STEBICEF), University of Palermo, Palermo, Italy.
Andrea FirrincieliDepartment of Pharmacy and Biotechnology (FaBiT), University of Bologna, Bologna, Italy.
Raymond J TurnerDepartment of Biological Sciences, Calgary University, Calgary, AB, Canada.
Davide ZannoniDepartment of Pharmacy and Biotechnology (FaBiT), University of Bologna, Bologna, Italy.
University of Bologna · ITNational Interuniversity Consortium of Materials Science and Technology · ITUniversity of Calgary · CAUniversity of Palermo · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bacteria belonging to Rhodococcus genus represent ideal candidates for microbial biotechnology applications because of their metabolic versatility, ability to degrade a wide range of organic compounds, and resistance to various stress conditions, such as metal toxicity, desiccation, and high concentration of organic solvents. Rhodococcus spp. strains have also peculiar biosynthetic activities that contribute to their strong persistence in harsh and contaminated environments and provide them a competitive advantage over other microorganisms. This review is focused on the metabolic features of Rhodococcus genus and their potential use in biotechnology strategies for the production of compounds with environmental, industrial, and medical relevance such as biosurfactants, bioflocculants, carotenoids, triacylglycerols, polyhydroxyalkanoate, siderophores, antimicrobials, and metal-based nanostructures. These biosynthetic capacities can also be exploited to obtain high value-added products from low-cost substrates (industrial wastes and contaminants), offering the possibility to efficiently recover valuable resources and providing possible waste disposal solutions. Rhodococcus spp. strains have also recently been pointed out as a source of novel bioactive molecules highlighting the need to extend the knowledge on biosynthetic capacities of members of this genus and their potential utilization in the framework of bioeconomy. KEY POINTS: • Rhodococcus possesses promising biosynthetic and bioconversion capacities. • Rhodococcus bioconversion capacities can provide waste disposal solutions. • Rhodococcus bioproducts have environmental, industrial, and medical relevance. Graphical abstract.

Indexed as

Refuse DisposalRhodococcusBiotechnologyIndustrial WasteTriglyceridesIndustrial WasteTriglyceridesAntimicrobialsBioconversionBioflocculantsBiosurfactantsBiosynthesisCarotenoidsLipidsMetal-based nanostructuresRhodococcusSiderophores

Identifiers

PMID32918579
PMCPMC7502451
OpenAlexW3086846606

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.